(Q26865398)

author name string

Christopher J. Borgert

series ordinal

1

1 reference

Stephen P. Baker

series ordinal

2

1 reference

John C. Matthews

series ordinal

3

1 reference

language of work or name

1 reference

October 2013

1 reference

Regulatory Toxicology and Pharmacology

published in

1 reference

volume

67

1 reference

issue

1

1 reference

page(s)

83-8

1 reference

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Application of key events analysis to chemical carcinogens and noncarcinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

A critical review of methods for comparing estrogenic activity of endogenous and exogenous chemicals in human milk and infant formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Predicted-no-effect concentrations for the steroid estrogens estrone, 17β-estradiol, estriol, and 17α-ethinylestradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

The elusive nature of intrinsic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Pharmacology and clinical use of sex steroid hormone receptor modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Courage for simplification and imperfection in the 21st century assessment of "Endocrine disruption".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Adverse drug reactions: definitions, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Environmental endocrine modulators and human health: an assessment of the biological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Principles for modulation of the nuclear receptor superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Principles: receptor theory in pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Endocrine disruption: historical perspectives and its impact on the future of toxicology testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally repre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Reproductive toxicants have a threshold of adversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Embryotoxicity of Norlestrin, a combined synthetic oral contraceptive, in rhesus macaques (Macaca mulatta).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Stimulation of growth of human breast cancer cell lines in culture by linoleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Flaxseed Does Not Enhance the Estrogenic Effect of Low-Dose Estrogen Therapy on Markers of Uterine Health in Ovariectomized Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

How much is enough? Modulation of dose-response curve for steroid receptor-regulated gene expression by changing concentrations of transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

What goes on behind closed doors: physiological versus pharmacological steroid hormone actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Low-dose in utero effects of xenoestrogens in mice and their relevance to humans: an analytical review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2013.06.007

10.1016/J.YRTPH.2013.06.007

7 January 2021

Identifiers

DOI

0 references

PubMed publication ID

23838262

1 reference